SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034697
Filing Date
2024-11-13
Accepted
2024-11-13 09:16:53
Documents
44
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20240930_10q.htm   iXBRL 10-Q 1016685
2 EXHIBIT 31.1 ex_721697.htm EX-31.1 16158
3 EXHIBIT 31.2 ex_721698.htm EX-31.2 14655
4 EXHIBIT 32.1 ex_721699.htm EX-32.1 8391
  Complete submission text file 0001437749-24-034697.txt   4967855

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20240930.xsd EX-101.SCH 39598
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20240930_cal.xml EX-101.CAL 19142
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20240930_def.xml EX-101.DEF 284054
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20240930_lab.xml EX-101.LAB 270839
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20240930_pre.xml EX-101.PRE 303662
47 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20240930_10q_htm.xml XML 789220
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 241451497
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)